WHO ICTRP trial
The effect of fluoxetine in improving the quality of life in patients with…
IRCT2015012220751N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015012220751N1 |
|---|---|
| Public title | The effect of fluoxetine in improving the quality of life in patients with cancer |
| Scientific title | Comparison of fluoxetine and placebo in improving the quality of life in patients with solid cancers referred to Imam Khomeini Hospital of Ardabil (double blind study) |
| Primary sponsor | Ardabil University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | cancer. Malignant neoplasm of stomach;Malignant neoplasm of stomach |
| Interventions | Intervention 1: Control group : oral prescription of similar placebo daily for 12 weeks. Intervention 2: Intervention group:oral prescription of fluoxetine capsules 20 mg daily for 12 weeks.;Treatment - Drugs;Treatment - Drugs;Control group… |
| Registration date | Feb 18, 2015 |
| Target size | 150 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: